Neuraxis, Inc. share price logo

Neuraxis, Inc. Share Price

NYSE: NRXS

Small Cap

$7.35

+0.35

(+5.00%)

as on

Neuraxis, Inc. Stock Performance

as on April 17, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $6.91
    $7.47
    downward going graph

    5.99%

    Downside

    1.63%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.33
    $7.97
    downward going graph

    81.90%

    Downside

    8.44%

    Upside

    downward going graph

Neuraxis, Inc. share price movements today

Previous Close
$7.00
Open
$7.02
Volume
302.2K
Day's Low - High
$6.91 - $7.47
52 Week Low - High
$1.33 - $7.97

Neuraxis, Inc. Historical Returns

1 Month Return
-0.71 %
3 Month Return
+ 53.17 %
1 Year Return
+ 332.1 %
3 Year Return
0 %
5 Year Return
0 %

Neuraxis, Inc. Stock Fundamentals & Key Indicators

Check Neuraxis, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$78.3M

EPS (TTM)

-0.54

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-7.1M

Revenue (TTM)

3.6M

Profit Margin

-218.55%

Return On Equity TTM

-285.36%

Neuraxis, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Neuraxis, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Neuraxis, Inc. image
Neuraxis, Inc.
BUY$78.3MNANA-218.55%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$44.5B140.06%143.098.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$112.4B101.33%28.8132.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$36.7BNA124.985.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$79.7B50.01%18.1831.41%

Stock Returns calculator for Neuraxis, Inc. Stock including INR - Dollar returns

The Neuraxis, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Neuraxis, Inc. investment value today

Current value as on today

₹4,94,374

Returns

₹3,94,374

(+394.37%)

Returns from Neuraxis, Inc. Stock

₹3,53,704 (+353.7%)

Dollar Impact

₹40,670 (+40.67%)

Analyst Recommendation on Neuraxis, Inc. Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Neuraxis, Inc.. Average target price of $11

Neuraxis, Inc. Share Price Target

Get share price movements and forecasts by analysts on Neuraxis, Inc..

What analysts predicted

33.18%UPSIDE

Target Price

$11

Current Price

$7.35

Analyzed by

7 Analysts

Target

$11.00

Neuraxis, Inc. target price $11, a slight upside of 33.18% compared to current price of $7.35. According to 7 analysts rating.

Neuraxis, Inc. Stock’s Investor Sentiment and Interest

Search interest for Neuraxis, Inc. Stock has increased by 892% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:892% versus previous 30 day period

Neuraxis, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-3
-1
-1
-2
-1
-1
-2
-1
-2
-1
EBITDA
-7
-1
-2
-2
-1
-1
-2
-1
-2
-1
Interest Expense
1
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-8
-5
-2
-2
-1
-1
-2
-1
-2
-1
Income Tax Expense
1
0
0
0
-
-
-
-
-
-
Net Income
-8
-5
-2
-2
-1
-1
-2
-1
-2
-1
Net Profit Margin
-1806.51%
-999.76%
-327.95%
-477.14%
-263.30%
-190.22%
-254.42%
-189.07%
-261.62%
-176.49%

Neuraxis, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
2
2
2
2
3
Gross Profit
1
2
2
2
2
3
Operating Income
-4
-2
-3
-6
-7
-7
EBITDA
-3
-2
-4
-9
-7
-7
Interest Expense
0
0
0
5
0
0
Depreciation
0
0
0
0
0
0
Income Before Tax
-3
-3
-4
-14
-8
-7
Income Tax Expense
0
0
0
5
-8
-
Net Income
-3
-3
-4
-14
-8
-7
Net Profit Margin
-193.04%
-111.27%
-178.05%
-594.57%
-306.84%
-218.55%

Neuraxis, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-5
-2
-2
-1
-1
-2
-1
-2
-1
Operating Cash Flow
-2
-1
-1
-1
-1
-1
-1
-1
-1
Investing Cash Flow
-
0
0
0
-
0
0
-
0
Financing Cash Flow
1
1
3
0
5
0
5
0
2
Change in Cash
0
0
1
-1
3
-1
3
-1
0

Neuraxis, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-3
-4
-14
-8
-7
Operating Cash Flow
-2
-2
-6
-6
-6
Investing Cash Flow
0
0
0
0
0
Financing Cash Flow
0
2
6
9
7
Change in Cash
-1
0
0
3
1

Insights on Neuraxis, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, NRXS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, NRXS stock has moved up by 53.2%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -2.12M → -1.70M (in $), with an average increase of 24.2% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 811.41K → 968.12K (in $), with an average increase of 16.2% per quarter

About Neuraxis, Inc.

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.
OrganisationNeuraxis, Inc.
Headquarters11611 North Meridian St, Carmel, IN, United States, 46032
IndustryBiotechnology
CEOMr. Brian Carrico
E-voting on sharesClick here to vote

Key Management of Neuraxis, Inc.

Name

Title

Dr. Adrian Miranda

Senior VP of Science & Technology and Chief Medical Officer

Dr. Thomas Carrico

Chief Regulatory Officer and Compliance & Privacy Officer

Dr. Christopher Robin Brown D.D.S.

Founder, Director of Innovation & Director

Mr. Behnam Shamsian CPA

Investor Relations

Mr. Brian Carrico

President, CEO & Director

Mr. Timothy Robert Henrichs

Chief Financial Officer

FAQs

What is Neuraxis, Inc. share price today?

Neuraxis, Inc. share price today is $7.35 as on at the close of the market. Neuraxis, Inc. share today touched a day high of $7.47 and a low of $6.91.

What is the 52 week high and 52 week low for Neuraxis, Inc. share?

Neuraxis, Inc. share touched a 52 week high of $7.97 on and a 52 week low of $1.33 on . Neuraxis, Inc. stock price today i.e. is closed at $7.35,which is 7.78% down from its 52 week high and 452.63% up from its 52 week low.

What is Neuraxis, Inc.'s market capitalisation today?

Neuraxis, Inc. market capitalisation is $0.00T as on .

How to invest in Neuraxis, Inc. Stock (NRXS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Neuraxis, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neuraxis, Inc. Shares that will get you 0.2041 shares as per Neuraxis, Inc. share price of $7.35 per share as on April 17, 2026 at 1:29 am IST.

What is the minimum amount required to buy Neuraxis, Inc. Stock (NRXS) from India?

Indian investors can start investing in Neuraxis, Inc. (NRXS) shares with as little as ₹93.289 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹932.89 in Neuraxis, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Neuraxis, Inc. share’s latest price of $7.35 as on April 17, 2026 at 1:29 am IST, you will get 1.3605 shares of Neuraxis, Inc.. Learn more about fractional shares .